Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands

• Published in: Emerging Infectious Diseases
• Main Authors: Petersen, Maria Skaalum, Strøm, Marin, Christiansen, Debes Hammershaimb, Fjallsbak, Jógvan Páll, Eliasen, Eina Hansen, Johansen, Malan, Veyhe, Anna Sofía, Kristiansen, Marnar Fríðheim, Gaini, Shahin, Møller, Lars Fodgaard, Steig, Bjarni, Weihe, Pál
• Format: Text
• Language: English
• Published: Centers for Disease Control and Prevention 2020
• Subjects: Research Letter; Faroe Islands
• Online Access: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588539/; http://www.ncbi.nlm.nih.gov/pubmed/32726200; https://doi.org/10.3201/eid2611.202736

We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% prevalence. Our findings will help us evaluate our public health response.